Status:
NOT_YET_RECRUITING
The Effect of Vitamin E Supplementation on Hospital Stay Duration in Non-cyanotic Heart Disease Children With Lower Respiratory Tract Infections
Lead Sponsor:
Assiut University
Conditions:
Respiratory Disease
Eligibility:
All Genders
2-5 years
Phase:
PHASE4
Brief Summary
Congenital heart disease can lead to serious health issues, particularly an increased risk of infections, specifically respiratory infections. Lower respiratory tract infections are the fifth leading ...
Detailed Description
Congenital heart disease can lead to serious health issues, particularly an increased risk of infections, specifically respiratory infections. Lower respiratory tract infections are the fifth leading ...
Eligibility Criteria
Inclusion
- Pediatric patients are diagnosed with non-cyanotic heart disease associated with severe lower respiratory tract infection. ⁃ The patients are aged 2 months to 5 years of both sexes.
Exclusion
- Pediatric patients that have other congenital anomalies other than CHD.
- Those with chronic respiratory diseases such as asthma, bronchiectasis, etc.).
- Immunocompromised patients, such as those who receive steroids or chemotherapy, etc.
- Pediatric patient that received vitamin E in the previous month.
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT06926712
Start Date
June 1 2025
End Date
June 1 2026
Last Update
April 15 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.